Here we showed that underlying the process of GADD45Akd enhanced chemo-sensitivity, the TP53 expression was decreased not only in wild-type (U87) but also in mutant (U373, T98) TP53-expressing GBM cells. The gene discussed is TP53; the disease is glioblastoma.